NICE Guidelines and Mounjaro: What the Guidance Covers

NICE has published separate guidance covering tirzepatide (Mounjaro) in two clinical areas: weight management in adults with obesity or overweight, and blood glucose management in adults with type 2 diabetes. Both pieces of guidance set out the conditions under which tirzepatide may be recommended — such as specific BMI thresholds, the presence of at least one weight-related health condition, or inadequate blood glucose control with existing medicines. The precise eligibility criteria and any restrictions are detailed in the published NICE technology appraisals.

Weight management guidance

NICE guidance in the weight management context generally applies to adults with a BMI above a defined threshold who also have at least one weight-related condition, such as high blood pressure, raised cholesterol, or obstructive sleep apnoea. The guidance typically specifies that tirzepatide should be used alongside a reduced-calorie diet and increased physical activity, and that it is intended for specialist or managed care settings rather than routine primary care in all cases. Your prescriber will have considered these criteria before issuing your prescription.

Type 2 diabetes guidance

In the context of type 2 diabetes, NICE guidance on tirzepatide covers its use as an add-on treatment when blood glucose is not adequately controlled by other medicines. The criteria relate to HbA1c levels, existing treatment regimens, and relevant clinical factors. Again, these are criteria your prescriber applies — they are not a checklist for patients to self-assess.

An important framing note

NICE guidance is produced for the UK and applies within UK health systems. If you are outside the UK, your country will have its own regulatory and clinical guidance bodies, and your prescriber will be working within those frameworks. The clinical principles — supervised use, eligibility assessment, combined lifestyle changes — tend to be broadly similar across well-regulated systems, but the specific rules differ. Always rely on your prescriber or doctor for guidance that applies to your situation. For further detail on the published appraisals, the NICE website is the authoritative source.

For a broader overview of how tirzepatide is used and what it involves, see our guide to everything you need to know about Mounjaro, or explore Mounjaro prescribing guidelines for more context on how clinical recommendations are applied in practice.

Once you have been prescribed Mounjaro under any clinical framework, the practical challenge shifts to consistency — taking each dose on schedule, monitoring how you feel, and building the lifestyle habits the guidance recommends alongside the medicine. That is where a dedicated tracking tool makes a real difference.

GLP Trackr's dose logging and reminder feature lets you record every injection — date, dose strength, and site — so your weekly schedule is always clear and a dose is never accidentally missed or doubled. Because NICE guidance and similar frameworks typically require Mounjaro to be used alongside dietary changes and increased activity, the app's food logging (including an AI photo scan that identifies calories and protein from a snapshot of your meal) and progress tracking help you build the evidence that you are engaging with the full programme your prescriber recommended.

The app also generates a doctor report — a clear summary of your logged doses, weight trend, food intake, and side effects — which can be genuinely useful when attending a review appointment or discussing whether your current approach is working well.

For more detail on the clinical framework surrounding Mounjaro prescriptions, take a look at NICE guidance on Mounjaro and our overview of Mounjaro prescribing guidelines.

If you experience any symptoms that concern you, or have questions about whether your current dose or treatment plan is right for you, contact your prescriber or doctor — they have access to your full medical history and are best placed to advise. GLP Trackr records your journey to support those conversations; it is not a substitute for clinical judgement.

Ready to bring your whole Mounjaro journey into one place? Download GLP Trackr on the App Store or Google Play and try it free for 7 days — no commitment needed.